EUVIMEDEUVIMED entdecken
Crossref

Dosimetric evaluation of megavoltage X‐ray and proton minibeam radiation therapy in brain tumor‐bearing canines

Alfredo Fernandez-Rodriguez, Sébastien Perrot, Jerôme Benoit, Yolanda Prezado

Medical Physics · 2025-12 · 52 (12)

DOI: 10.1002/mp.70186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Physics, online erschienen am 02.12.2025. Verfasst von Alfredo Fernandez-Rodriguez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institut Curie, Université PSL, Centre national de la recherche scientifique (CNRS) UMR3347, Inserm U1021, Signalisation radiobiologie et cancer, Ors…. Hauptthemen laut MEDLINE: Brain Neoplasms, Proton Therapy, X-Ray Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: European Research Council (ERC), European Union's Horizon 2020, joint Imperial College London-CNRS PhD program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Healthy tissue toxicity is the main limitation for the treatment of brain tumors using radiotherapy (RT). Megavoltage X‐ray Minibeam Radiation Therapy (MBRT) and proton Minibeam Radiation Therapy (pMBRT) are novel therapeutic approaches demonstrated to reduce healthy tissue toxicity, enhancing the therapeutic possibilities of challenging cases. Owing to the different radiation types delivering the dose, their dosimetric properties may make one approach more suitable than the other depending on tumor type and location. While both techniques have been extensively studied in small animal models, canine clinical studies provide a closer approximation to human conditions.

Purpose

This study aims to compare the dosimetric performance of MBRT and pMBRT in canine brain tumors and to determine which modality provides more favorable dose distributions depending on tumor location.

Methods

Three representative cases were chosen, and MBRT and pMBRT treatments for a prescribed dose of 26 Gy to the planning target volume (PTV) were simulated using Monte Carlo methods. The in‐depth evolution of the minibeam patterns was investigated for both modalities. The dose distributions within the PTV, healthy brain and surrounding tissues evaluated by calculating and comparing the corresponding peak, valley, and mean doses. Results pMBRT achieves dosimetric superiority for tumors in the rostral cerebrum surrounded by highly heterogeneous tissue with one entry port. MBRT achieves optimal dose distributions in a two‐beam configuration for deeper and more centered targets, where the reduced lateral spread of X‐ray minibeams preserved dose heterogeneity.

Conclusions

In this dosimetric comparison of MBRT and pMBRT for the treatment of spontaneous canine brain tumors, the distinct in‐depth physical behavior of X‐ray and proton minibeams makes each modality more suitable for specific target locations to achieve optimal dose distributions. These findings provide valuable guidance for future veterinary clinical trials and represent an important step toward the clinical implementation of MBRT and pMBRT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsProton TherapyX-Ray TherapyDogsAnimalsRadiotherapy DosageRadiometryMonte Carlo MethodRadiotherapy Planning, Computer-Assisted

Stichwörter der Autor:innen

DosimetryMinibeam radiotherapyMonte Carlo

Autor:innen und Institutionen

  • Institut Curie, Université PSL, Centre national de la recherche scientifique (CNRS) UMR3347, Inserm U1021, Signalisation radiobiologie et cancer, Orsay, France.
  • Université Paris-Saclay, Centre national de la recherche scientifique (CNRS) UMR3347, Inserm U1021, Signalisation radiobiologie et cancer, Orsay, France.
  • ONCOVET, IVC Evidensia France, Villeneuve-d'Ascq, France.
  • IVC Evidensia France, Courbevoie, France.
  • New Approaches in Radiotherapy Lab, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), University of Santiago de Compostela, A…
  • Oportunius Program, Galician Agency of Innovation (GAIN), Xunta de Galicia, A Coruña, Spain.

Förderung

  • European Research Council (ERC)
  • European Union's Horizon 2020
  • joint Imperial College London-CNRS PhD program
  • Centre de Calcul (TGCC) of Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA)

Zitieren

APA

Fernandez-Rodriguez, A., Perrot, S., Benoit, J., & Prezado, Y. (2025). Dosimetric evaluation of megavoltage X‐ray and proton minibeam radiation therapy in brain tumor‐bearing canines. Medical Physics, 52(12). https://doi.org/10.1002/mp.70186

Vancouver

Fernandez-Rodriguez A, Perrot S, Benoit J, Prezado Y. Dosimetric evaluation of megavoltage X‐ray and proton minibeam radiation therapy in brain tumor‐bearing canines. Medical Physics. 2025;52(12). doi:10.1002/mp.70186

BibTeX
@article{FernandezRodriguez2025,
  author = {Fernandez-Rodriguez, Alfredo and Perrot, Sébastien and Benoit, Jerôme and Prezado, Yolanda},
  title = {Dosimetric evaluation of megavoltage X‐ray and proton minibeam radiation therapy in brain tumor‐bearing canines},
  journal = {Medical Physics},
  year = {2025},
  volume = {52},
  number = {12},
  doi = {10.1002/mp.70186}
}
Kostenlos starten →